Doximity/$DOCS
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Doximity
Doximity Inc is a digital platform for U.S. medical professionals. The cloud-based platform provides members with tools specifically built for medical professionals, enabling them to collaborate with their colleagues, securely coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers and on-call schedules.
Ticker
$DOCS
Sector
Primary listing
NYSE
Employees
830
Headquarters
Website
Doximity Metrics
BasicAdvanced
$14B
62.07
$1.17
1.36
-
Price and volume
Market cap
$14B
Beta
1.36
52-week high
$85.21
52-week low
$40.87
Average daily volume
1.3M
Financial strength
Current ratio
6.468
Quick ratio
6.202
Long term debt to equity
0.943
Total debt to equity
1.155
Profitability
EBITDA (TTM)
243.905
Gross margin (TTM)
90.14%
Net profit margin (TTM)
39.88%
Operating margin (TTM)
40.57%
Effective tax rate (TTM)
14.36%
Revenue per employee (TTM)
$710,000
Management effectiveness
Return on assets (TTM)
13.13%
Return on equity (TTM)
24.25%
Valuation
Price to earnings (TTM)
62.068
Price to revenue (TTM)
23.069
Price to book
13.26
Price to tangible book (TTM)
14.54
Price to free cash flow (TTM)
47.339
Free cash flow yield (TTM)
2.11%
Free cash flow per share (TTM)
1.533
Growth
Revenue change (TTM)
19.45%
Earnings per share change (TTM)
45.79%
3-year revenue growth (CAGR)
17.71%
3-year earnings per share growth (CAGR)
19.69%
What the Analysts think about Doximity
Analyst ratings (Buy, Hold, Sell) for Doximity stock.
Bulls say / Bears say
Q4 FY2025 total revenues grew 17% YoY to $138.3 million, while free cash flow surged 56% to $97 million, underscoring robust profitability and cash generation. (BusinessWire)
In Q1 FY2026, revenue rose 15% YoY to $145.9 million with non-GAAP net income margin expanding to 49.2%, and the AI suite grew 5× YoY alongside 630,000 prescribers using workflow tools, demonstrating strong user engagement and operational leverage. (BusinessWire)
The $63 million acquisition of Pathway Medical brings one of the largest structured medical AI datasets to Doximity’s platform, significantly enhancing its clinical AI capabilities and competitive positioning. (BusinessWire)
YoY top-line growth slowed from 17% in Q4 to 15% in Q1, suggesting decelerating revenue momentum. (BusinessWire) (BusinessWire)
Operating cash flow declined by 37% sequentially from $98.5 million in Q4 to $62.1 million in Q1, raising questions about consistency in cash generation. (BusinessWire) (BusinessWire)
General and administrative expenses rose 34% YoY to $12.4 million in Q1, indicating rising overhead that may pressure margins. (BusinessWire)
Data summarised monthly by Lightyear AI. Last updated on 9 Oct 2025.
Doximity Financial Performance
Revenues and expenses
Doximity Earnings Performance
Company profitability
Doximity News
AllArticlesVideos
Doximity, Inc. Long-Term Shareholder Announcement: Johnson Fistel Encourages Investors to Reach Out For More Information About Continuing Investigation
Business Wire1 week ago
Doximity, Inc. Long-Term Shareholder Announcement: Johnson Fistel Encourages Investors to Reach Out For More Information About Continuing Investigation
Business Wire1 month ago
Doximity Analysts Increase Their Forecasts After Strong Q1 Earnings
Benzinga2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Doximity stock?
Doximity (DOCS) has a market cap of $14B as of October 10, 2025.
What is the P/E ratio for Doximity stock?
The price to earnings (P/E) ratio for Doximity (DOCS) stock is 62.07 as of October 10, 2025.
Does Doximity stock pay dividends?
No, Doximity (DOCS) stock does not pay dividends to its shareholders as of October 10, 2025.
When is the next Doximity dividend payment date?
Doximity (DOCS) stock does not pay dividends to its shareholders.
What is the beta indicator for Doximity?
Doximity (DOCS) has a beta rating of 1.36. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.